The software platform includes a range of security and compliance features to help organizations meet the requirements of FDA 21 CFR Part 11. It is important to note that compliance is an ongoing process, so organizations should regularly monitor and update their systems and policies to ensure adherence to the standards established by the FDA.
Title 21 CFR Part 11 is part of Title 21 of the Code of Federal Regulations and establishes the United States Food and Drug Administration (FDA) regulations on electronic records and electronic signatures (ERES).
On this page:
The software platform includes a range of security and compliance features to help organizations meet the requirements of FDA 21 CFR Part 11. It is important to note that compliance is an ongoing process, so organizations should regularly monitor and update their systems and policies to ensure adherence to the standards established by the FDA.
Title 21 CFR Part 11 is part of Title 21 of the Code of Federal Regulations and establishes the United States Food and Drug Administration (FDA) regulations on electronic records and electronic signatures (ERES).
Part 11 defines the criteria under which electronic records and electronic signatures are considered trustworthy, reliable, and equivalent to paper records.
Listed below are security-related features available in the product:
FDA validation requires separate environments for Development, Validation, and Production. FrameworX's Execution Profiles feature enables this separation without manual configuration changes.
Navigate to Runtime → Execution Profiles
Configure Development Profile:
- Select: Development tab
- Enable Profile Settings: ?
- Set ReadOnly on Modules: Select modules to protect
- Configure test database connections
Configure Validation Profile:
- Select: Validation tab
- Enable Profile Settings: ?
- Set ReadOnly on Modules: ? All modules
- Use validation database connections
Production Profile:
Navigate to Security → Policies and create FDA-compliant policy:
Identification Settings:
AllowPasswordChange: True
PasswordMinLength: 8
BlockOnInvalidAttempts: 3 (automatic blocking)
AllowShareUser: False
UserNameMinLength: 6
PasswordHistory: 5
MinPasswordAge: 24 (hours)
MaxPasswordAge: 2160 (90 days)
BlockAging: 24 (hours)
ESign Settings:
Enabled: True
TimeoutMinutes: 5
Session Settings:
AutoLogOff: Both
InactivityMinutes: 15
DurationHours: 12
In Security → Users, create standard FDA roles:
Role | Policy | Permissions | Typical Users |
---|---|---|---|
Administrator | FDA_Compliant | Full system access | System Admin |
Supervisor | FDA_Compliant | Approve batches, modify recipes | Production Manager |
Operator | FDA_Compliant | Run processes, acknowledge alarms | Operators |
Viewer | FDA_Compliant | Read-only access | QA Inspector |
Go to Alarms → Global Settings
Configure:
? Enable Audit Trail
Retention Days: 2555 (7 years minimum)
Database: [Select SQL database]
Select events to audit:
? User Logon/Logoff
? Open/Close Displays
? Remote Connections
? Custom Messages
? Tag Changes
? Datasets (Save/Load or Modify)
? Operator Actions
? Save Reports
? System Warnings
For each critical tag requiring audit:
Configure signature meanings in Audit Trail messages:
Navigate to Track Changes Tables to monitor:
Use Version Control to:
? Rebuild All? Validate DisplaysVersion: Set appropriate version (e.g., 1.0)
The published .dbrun file:
To comply with regulation requirements for digital and physical copies:
Go to Reports → Forms
Configure report properties:
Name: [Report Name]
SaveFormat: PDF (for archival)
SaveFileName: {path with timestamp}
EditSecurity: [Authorized groups only]
Add runtime objects:
@Report.<ReportName>.Save
// or with orientation
@Report.<ReportName>.SaveCommand(0) // Portrait
@Report.<ReportName>.SaveCommand(1) // Landscape
This table serves as a checklist for certification:
Item | Description | Reference | FrameworX Implementation |
---|---|---|---|
1 | Software validation per FDA/GAMP guidelines | FDA 21 CFR Part 11 | Execution Profiles, Publish feature |
2 | Default password change at first access | FDA 21 CFR Part 11 | Security Policies configuration |
3 | Electronic format reports (PDF, XPS) | FDA 21 CFR Part 11 11.10(b) | Reports module with PDF/XPS support |
4 | Printed copies for audit records | FDA 21 CFR Part 11 11.10(b) | TLib.PrintXPS method |
5 | Long-term record availability | FDA 21 CFR Part 11 11.10(c) | Configurable retention in solution |
6 | Data archiving capability | FDA 21 CFR Part 11 11.10(c) | Historian module |
7 | Role-based access control | FDA 21 CFR Part 11 11.10(d) | Security module with roles/groups |
8 | Unique user identification | FDA 21 CFR Part 11 11.10(d) | Username/password system |
9 | 8-character minimum password | FDA 21 CFR Part 11 11.10(d) | PasswordMinLength setting |
10 | Password expiration and history | FDA 21 CFR Part 11 11.10(d) | Security Policies configuration |
11 | Account blocking on failed attempts | FDA 21 CFR Part 11 11.10(d) | BlockOnInvalidAttempts setting |
12 | Session timeout capability | FDA 21 CFR Part 11 11.10(d) | AutoLogOff configuration |
13 | Comprehensive audit trail | FDA 21 CFR Part 11 11.10(e) | Audit Trail in SQL database |
14 | Record deletion prevention | FDA 21 CFR Part 11 11.10(e) | Database configuration |
15 | Complete audit information | FDA 21 CFR Part 11 11.10(e) | User, timestamp, action tracking |
16 | Audit trail retention | FDA 21 CFR Part 11 11.10(e) | Configurable retention period |
17 | Server-based timestamps | FDA 21 CFR Part 11 11.10(e) | Server time enforcement |
18 | Process action auditing | FDA 21 CFR Part 11 11.10(e) | Alarm and Dataset modules |
19 | User activity monitoring | FDA 21 CFR Part 11 11.10(e) | Native platform feature |
20 | Audit report generation | FDA 21 CFR Part 11 11.10(e) | PDF/XPS report creation |
21 | Process sequence control | FDA 21 CFR Part 11 11.10(f) | Dataset module and Scripts |
22 | Electronic signature information | FDA 21 CFR Part 11 11.50(a) | ESign with user/timestamp |
23 | Action documentation | FDA 21 CFR Part 11 11.50(a3) | Audit Trail messages |
24 | Signature display | FDA 21 CFR Part 11 11.50(b) | Reports module |
25 | Unique signatures per user | FDA 21 CFR Part 11 11.100(a) | Security module enforcement |
26 | Signature history maintenance | FDA 21 CFR Part 11 11.200(a2) | Datasets module |
27 | Signature binding to records | FDA 21 CFR Part 11 11.200(a2) | Security and Datasets integration |
FrameworX provides comprehensive features supporting FDA 21 CFR Part 11 compliance through its integrated security, audit trail, electronic signature, and validation environment capabilities. Proper configuration and procedural controls, combined with these technical features, enable organizations to achieve and maintain compliance with FDA regulations.
Part 11, commonly referred to as, defines the criteria under which electronic records and electronic signatures are considered trustworthy, reliable, and equivalent to paper records.
Listed below are some security-related features available in the product:
Audit trails should be generated independently of the operator and include the local date and time of the actions that alter the record. They cannot overwrite old data and must be stored as long as the record itself is stored.
To use the Audit Trail function, you must enable it. Go to Alarms / Global Settings, and click the “Enable Audit Trail” checkbox.
After it’s enabled, you can choose which actions will be stored in the Audit Trail database. The options are as follows:
For every solution update indicated above, crucial information is stored alongside the event info in the Alarm Historian database columns:
To comply with the regulation, the software must be able to export digital and physical copies of Reports.
To create or edit a report:
It is possible to add several runtime objects to a Report. Some examples are:
The Report is saved using one of the following methods:
@Report.<ReportName>.Save // Property used to trigger the save report action @Report.<ReportName>.SaveCommand(int Orientation) // Orientation = 0 or blank -- Portrait Mode // Orientation = 1 -- Landscape Mode // saves the selected report into the path indicated by the SaveFileName property |
This table can be used as check list and auxiliary tool on the certification process.
Electronic Records and Electronic Signatures Compliance | ||||
---|---|---|---|---|
Item | Description | Reference | Software Platform | |
1 | The software must be validated, according to the current guidelines established by the FDA and GAMP. | FDA 21 CFR Part 11 | Publish resources, native to the software platform. | |
2 | The software must have control that defines the default password exchange, performed by the user, at the first access. | FDA 21 CFR Part 11 | Implemented in Logon dialog, native to the software platform. | |
3 | The software must allow copies of reports in electronic format PDF, XML, and other to be viewed and referenced when necessary. | FDA 21 CFR Part 11 11.10 ( b ) | It is possible to save files in PDF and XPS. The XPSViewer control is part of the software platform. For PDF, the IE control, or the native report viewer can be used. | |
4 | The software must allow printed copies of the reports to be generated for the requested audit records. | FDA 21 CFR Part 11 11.10 ( b ) | You can save the report in XPS and then print it using the "TLib.PrintXPS" method. | |
5 | Electronic records should be available for consultation and for as long as needed. Established historical basis of the production base should be established. | FDA 21 CFR Part 11 11.10 ( c ) | Configurable in the solution. | |
6 | The software must allow the archiving of the generated data. | FDA 21 CFR Part 11 11.10 ( c ) | Historian module, native to the software platform. | |
7 | The software must have access control with different user profiles / groups such as operational level, administrator level and maintenance level. | FDA 21 CFR Part 11 11.10 ( d ) | Native to the software platform. | |
8 | The software shall permit the unique identification of the user (Username & password). | FDA 21 CFR Part 11 11.10 ( d ) | Native to the software platform. | |
9 | The software must control the minimum length of 8 characters to the user's password and accept upper and lower case characters. | FDA 21 CFR Part 11 11.10 ( d ) | Native to the software platform. | |
10 | The software must require password expiration to occur according to the registered period (term in days). Ensure that the last 5 passwords are not reused and blocking access if the user does not change the password when requested. | FDA 21 CFR Part 11 11.10 ( d ) | Can be implemented via DialogOnOK script in Logon dialog. | |
11 | The user who promotes three unsuccessful access attempts (wrong password) should have their access blocked. The same can only be reactivated by the administrator and, recorded on the audit trail. | FDA 21 CFR Part 11 11.10 ( d ) | Can be implemented via DialogOnOK script in Logon dialog. | |
12 | The software must have a "timeout" function that can be triggered after a certain period in which the Logged in user is idle. | FDA 21 CFR Part 11 11.10 ( d ) | The software platform has the setting for AutoLogOff after an inactivity, or session length. | |
13 | The software must have an "Audit trail", where all actions related to the creation, alteration and deletion of electronic records are kept. | FDA 21 CFR Part 11 11.10 ( e ) | The software platform has an Audit Trail in a SQL database, it can include the commands that involve electronic records. | |
14 | The software should not allow the deletion of the electronic records. | FDA 21 CFR Part 11 11.10 ( e ) | Configurable in the software platform Alarm and Database modules. | |
15 | "Audit Trail" must record date, time and user first and last followed by any changed information, referring to the action performed. | FDA 21 CFR Part 11 11.10 ( e ) | Configurable in the software platform Alarm and Database modules. | |
16 | The software must allow information from the "Audit Trail" to be maintained over the same reporting period. | FDA 21 CFR Part 11 11.10 ( e ) | Archiving time is configurable in the solution. | |
17 | Date and time of the "Audit Trail" should be recorded based on the Server, and cannot be generated from a location that can be altered. | FDA 21 CFR Part 11 11.10 ( e ) | Native to the software platform. | |
18 | The "Audit trail" must contain actions of the process, that are related to the creation, change, activation or deletion of electronic records. | FDA 21 CFR Part 11 11.10 ( e ) | Configurable through the Alarm and Dataset modules in the software platform. | |
19 | The software must monitor active and inactive user activity. | FDA 21 CFR Part 11 11.10 ( e ) | Native to the software platform. | |
20 | The software should allow for the generation of copies of the Audit trail report, both in electronic and printed form. | FDA 21 CFR Part 11 11.10 ( e ) | The software platform reporting allows for the creation of PDF and XPS files and online viewing. | |
21 | The software should control the execution of activities according to the process sequence. | FDA CFR 21 Part 11 11.10 ( f ) | Configurable in the Dataset module and Scripting engine inside the software platform. | |
22 | The electronic record, and electronic signature, shall contain the following user information: Full name of the user and date / time that the record was electronically signed. | FDA 21 CFR Part 11 11.50 ( a1 ) & 11.50 ( a2 ) | Resource available through Datasets modules inside the software platform. | |
23 | The electronic record shall contain the information of the actions carried out, such as execution, review, approval, explanation and electronic signature. | FDA 21 CFR Part 11 11.50 ( a3 ) | Resource available through Datasets modules inside the software platform. | |
24 | User information, (full name, date & time) that is electronically signed, shall appear in both the printed and electronic format. | FDA 21 CFR Part 11 11.50 ( b ) | Resource available through Datasets modules inside the software platform. | |
25 | The software should control unique signatures to each user. | FDA 21 CFR Part 11 11.10 ( d ) & 11.100 ( a ) | Resource available through Datasets and Security modules inside the software platform. | |
26 | The software must maintain the history of the electronics signatures used, even after the user has logged off. | FDA 21 CFR Part 11 11.10 ( d ) & 11.200 ( a2 ) | Resource available through Datasets modules inside the software platform. | |
27 | The software shall ensure that the electronic signature is related to electronic registration, and cannot be falsified. | FDA 21 CFR Part 11 11.10 ( d ) & 11.200 ( a2 ) | Resource available through Datasets and Security modules inside the software platform. |
In this section: